Search Results 801-810 of 19226 for hemoglobin

1. A Trial of the Effectiveness and Safety of CVL-865 to Treat Focal Onset Seizures - Mayo Clinic

   Participation eligibility · AST or ALT ≥ 2 x ULN; · Total bilirubin ≥ 1.5 x ULN. · Females: Hemoglobin < 11 g/dL | Males: hemoglobin < 12 g/dL; · White blood cell ...

2. A Study to Evaluate the da Vinci® Xi™ Surgical System in Nipple Sparing Mastectomy (NSM) Procedures - Mayo Clinic

   Subject has hemoglobin A1C levels ≥ 8. Subject has a high risk for anesthesia (ASA class ≥ IV) or significant medical comorbidities (i.e., cardiac ...

3. A Study to Determine the Effectiveness and Safety of Luspatercept in Patients with Myelodysplastic/ Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis - Mayo Clinic

   Requirement of red blood cell transfusions (≥ 2 units ≤ 8-weeks prior to registration) OR symptomatic anemia with hemoglobin < 9.5 g/dL OR hematocrit < 30 ...

4. Low-Dose or High-Dose Lenalidomide in Treating Children with Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dL (may receive red blood cell [RBC] transfusions); Creatinine clearance or radioisotope glomerular filtration rate(GFR) ≥ 70 mL/min/m^2 ...

5. Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency - Mayo Clinic

   Hemoglobin > 9.0 g/dL and < 13.5 g/dL (females) or <15.0 g/dL (males) within 28 days of randomization;; Serum ferritin < 100 ng/mL or 100 to 300 ng/mL with ...

6. A Study of Copanlisib and Nivolumab in Treating Participants With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell Lymphoma - Mayo Clinic

   Hemoglobin > 9.0 g/dL;; Total bilirubin ≤ 1.5 x upper limit of normal (ULN) (except patients with Gilbert Syndrome, who can have total bilirubin < 3.0 mg/dL); ...

7. A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies - Mayo Clinic

   Hemoglobin (Hgb) ≥ 10 g/dl; Total bilirubin £ 1.5 × ULN; Creatinine £ 1.5 ´ ULN or creatinine clearance > 60 mL/min/1.73 m2 for patients with creatinine ...

8. A Phase 2, Multi-center, Open-label Study to Evaluate the Efficacy and Safety of Luspatercept (ACE-536) in Subjects with Myeloproliferative Neoplasm-Associated Myelofibrosis and Anemia with and without Red Blood Cell-Transfusion Dependence - Mayo Clinic

   No subjects with an interval ≥ 42 days between hemoglobin measurements will be enrolled;; There must not be any RBC transfusions within the 84-day period ...

9. Selinexor in Advanced Liposarcoma - Clinical Trials

   Hemoglobin (Hb) ≥9 g/dL;; Transfusions, hematopoietic growth factors, and hematinics are NOT permitted during screening. Adequate hepatic function ...

10. Radiation Therapy with Durvalumab or Cetuximab to Treat Patients with Locoregionally Advanced Head and Neck Cancer who Cannot Take Cisplatin - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] ≥ 9.0 g/dl is acceptable) (within 14 days prior to ...